The authors present the case of a 62-year-old male patient with an implantable cardioverter-defibrillator and end-stage heart failure supported with an intra-aortic balloon pump. Implantation of a triple-site cardiac resynchronization system and complex heart failure treatment brought a...

Ventricular tachycardia (VT) is a major cause of sudden cardiac death (SCD) in patients with heart failure (HF). Left ventricular ejection fraction (LVEF) and heart failure class according to the New York Heart association (NYHA) are in most common use to identify patients that may benefit from...

The article discusses a research paper by A.S.L. Tang and colleagues which highlights the results of the Resynchronization-Defibrillation for Ambulatory Heart Failure Trial (RAFT). The study examined the effect of cardiac-resynchronization therapy (CRT) and implantable...

Introduction: Developing an ablation strategy when the clinical arrhythmia cannot be induced is a challenge. Methods and results: A 72-year-old man is transferred to our facility for ventricular tachycardia (VT) storm. Endocardial and epicardial voltage mapping was normal and program stimulation...

Discusses the abstract of the article 'Impending Sudden Cardiac Death: Treatment With Myocardial Revascularization and the Automatic Implantable Cardioverter Defibrillator,' by James D. Fonger et al., published in a 1988 issue of the 'Annals of Thoracic Surgery' journal.

Discusses the development of the automatic implantable cardioverter defibrillator (ACID). Design of the apparatus to detect and terminate ventricular tachycardia (VT) or fibrillation (VF); Evolution from an investigation to a clinical tool for management of malignant ventricular arrhythmias;...

The article discusses the importance of implantable cardioverter defibrillators (ICDs) in improving survival rates of sudden cardiac arrest (SCA) which results from a hemodynamically unstable heart rhythm such as ventricular fibrillation or ventricular tachycardia. It mentions that failure of...

Editorial. Assesses the progress of research on the clinical use of implantable cardioverter defibrillators (ICD). High risk for sudden and nonsudden death in patients with left ventricular dysfunction; Increased use of ICD since its introduction to clinical medicine in 1980; Need to refine...